yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Table
SPARQL
Graphs
2
2
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39681190-2B46A7F6-F423-4D8E-A8E8-B49D23BF3A83
Q39681190-2B46A7F6-F423-4D8E-A8E8-B49D23BF3A83
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39681190-2B46A7F6-F423-4D8E-A8E8-B49D23BF3A83
The Next Wave of Biological Agents for the Treatment of IBD: Evidence from Cochrane Reviews.
P2860
Q39681190-2B46A7F6-F423-4D8E-A8E8-B49D23BF3A83
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39681190-2B46A7F6-F423-4D8E-A8E8-B49D23BF3A83
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5a9b4f5766232bb9e3e513a2ef0b48378db63a61
P2860
New interleukin-23 pathway inhibitors in dermatology: ustekinumab, briakinumab, and secukinumab.